Strontium for Bone Health: Density, Fracture Prevention, and Safety

Strontium is a mineral chemically similar to calcium that has demonstrated remarkable effects on bone mineral density. The prescription form, strontium ranelate, was approved in Europe for osteoporosis after large clinical trials showed significant fracture reduction. In the supplement market, strontium citrate is available over the counter for bone support. Understanding what the evidence does and does not support is essential.

Quick answer

Strontium has a dual mechanism: it stimulates bone-building osteoblasts and inhibits bone-resorbing osteoclasts. Strontium ranelate reduced vertebral fractures by 41% and hip fractures by 36% in large trials. Strontium citrate (OTC) has not been studied in comparable trials. Important: strontium artificially inflates DEXA bone density readings by 8-12% due to its higher atomic weight. Take strontium at least 4 hours apart from calcium.

How strontium works

Strontium has about 99% of its body stores in bone, where it substitutes for calcium in the hydroxyapatite crystal lattice:

• Osteoblast stimulation — strontium activates the calcium-sensing receptor (CaSR) on osteoblasts, promoting bone formation. It also increases OPG (osteoprotegerin) production, which inhibits RANKL-mediated osteoclast activation.
• Osteoclast inhibition — strontium reduces the differentiation and activity of osteoclasts, the cells that break down bone
• Dual action — this "uncoupling" of bone formation (increased) and bone resorption (decreased) is unique among bone-health agents. Bisphosphonates only reduce resorption; most anabolic agents only increase formation.

Clinical evidence

Strontium ranelate (prescription)

The SOTI and TROPOS trials (large, multi-year RCTs) demonstrated:

• 41% reduction in vertebral fractures over 3 years (SOTI trial, n=1,649)
• 36% reduction in hip fractures in high-risk subgroup over 3 years (TROPOS trial, n=5,091)
• 14.4% increase in lumbar spine BMD at 3 years (though partially artifact; see DEXA section)
• Effects maintained over 5+ years of continued use

However: The European Medicines Agency restricted strontium ranelate in 2013 due to a small increased risk of cardiovascular events (myocardial infarction) and venous thromboembolism. It was subsequently withdrawn from several markets.

Strontium citrate (OTC supplement)

• No randomized controlled trials comparable to strontium ranelate
• Assumed to share the mechanism based on elemental strontium's actions
• The ranelate moiety may have independent biological effects, so extrapolating is uncertain
• Some practitioners use it empirically based on the ranelate data

The DEXA artifact

This is critical to understand. Strontium has a higher atomic weight than calcium (87.6 vs. 40.1). When incorporated into bone, strontium attenuates X-rays more than calcium, causing DEXA scans to overestimate true bone mineral density by approximately 8-12%.

This means:

• A portion of the "BMD increase" seen with strontium is an artifact, not real bone strengthening
• The fracture reduction data is real, but the BMD numbers are inflated
• If monitoring DEXA on strontium, the radiologist should be informed for proper interpretation

Dosing guidelines

| Purpose | Dose (elemental strontium) | |---|---| | Bone support (supplement) | 340-680 mg strontium citrate | | Strontium ranelate (Rx, where available) | 2 g/day (containing 680 mg strontium) | | Timing | Take at bedtime, 4+ hours after calcium |

The calcium separation rule: Strontium and calcium compete for absorption. Taking them together reduces absorption of both. Always separate strontium and calcium by at least 4 hours. Most people take calcium with meals and strontium at bedtime.

Safety considerations

• Cardiovascular risk — strontium ranelate was associated with a small increase in cardiovascular events. Whether this applies to strontium citrate at equivalent doses is unknown but should be considered.
• VTE risk — increased venous thromboembolism was seen with ranelate
• Contraindicated in — established cardiovascular disease, uncontrolled hypertension, peripheral arterial disease, cerebrovascular disease
• Kidney function — strontium is renally excreted; use with caution in kidney impairment
• GI effects — nausea and diarrhea are common initial side effects

FAQ

Is strontium citrate as effective as strontium ranelate?

Unknown. The fracture reduction evidence is exclusively from strontium ranelate trials. The citrate form provides the same elemental strontium, but the ranelate moiety may contribute independently. Strontium citrate is a reasonable option for people who want bone support but cannot access ranelate.

Does strontium really increase bone density, or is it a measurement artifact?

Both. Strontium does stimulate real bone formation and inhibit resorption, producing genuine increases in bone mass. However, DEXA readings overestimate the improvement by 8-12% due to strontium's higher X-ray attenuation. The fracture reduction in clinical trials confirms real structural benefit.

Can I take strontium with calcium and vitamin D?

Yes, but separate strontium from calcium by at least 4 hours. Vitamin D does not need to be separated. A typical protocol is: calcium and vitamin D with meals, strontium at bedtime.

Related Articles

• Strontium Bone Density Guide
• Best Supplements for Bone Health
• Vitamin K2 and Bone Health
• Calcium Supplement Guide

Track your supplements in Optimize.